ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Inhibikase Therapeutics Inc

Inhibikase Therapeutics Inc (IKT)

3.05
-0.01
(-0.33%)
Closed December 27 4:00PM
3.05
0.00
( 0.00% )
Pre Market: 4:55AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 63k65k116k80k0000
Operating Income -4.34M-4.72M-6.2M-4.77M-4.4M-4.78M-5.05M-5.83M
Pre Tax Income -4.28M-4.48M-5.78M-4.6M-4.18M-4.65M-4.96M-5.78M
Net Income -4.28M-4.48M-5.78M-4.6M-4.18M-4.65M-4.96M-5.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -4.34M-4.72M-6.2M-4.77M-4.4M-4.78M-5.05M-5.83M
EBITDA -4.33M-4.71M-6.04M-4.76M-4.4M-4.78M-5.05M-5.82M
Year End December 30 2023 201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 4.04M1.12M698k3.1M123k261k
Operating Income -2.12M-5.7M-2.82M-14.77M-18.13M-20.09M
Pre Tax Income -2.15M-5.72M-2.85M-14.79M-18.05M-19.03M
Net Income -2.15M-5.72M-2.85M-14.79M-18.05M-19.03M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -0.263-0.7-0.283-0.588-0.716-3.082
EBIT -2.12M-5.7M-2.82M-14.77M-18.13M-20.09M
EBITDA -2.12M-5.7M-2.82M-14.77M-18.12M-19.91M

Your Recent History

Delayed Upgrade Clock